(Q36808748)

16 August 2017

1 reference

title

Inherited thrombophilia: key points for genetic counseling (English)

1 reference

16 August 2017

1 reference

Elizabeth Varga

1

1 reference

16 August 2017

1 May 2007

1 reference

Journal of Genetic Counseling

16 August 2017

1 reference

16 August 2017

16

1 reference

16 August 2017

3

1 reference

16 August 2017

261-277

1 reference

Physician practices in the prevention of venous thromboembolism

16 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10897-006-9069-9

The thrombophilias: well-defined risk factors with uncertain therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-006-9069-9

5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-006-9069-9

The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-006-9069-9

Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-006-9069-9

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-006-9069-9

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-006-9069-9

Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome

21 January 2018

1 reference

12 December 2020

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

1 reference

12 December 2020

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study

1 reference

12 December 2020

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

12 December 2020

Venous thrombotic risk in family members of unselected individuals with factor V Leiden

1 reference

12 December 2020

Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S

1 reference

12 December 2020

Factor V Leiden mutation in cerebral venous thrombosis

1 reference

12 December 2020

Hyperhomocysteinemia and deep-vein thrombosis. A case-control study.

1 reference

12 December 2020

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

1 reference

12 December 2020

A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure

1 reference

12 December 2020

Venous thrombosis: prevalence and interaction of risk factors

1 reference

12 December 2020

Heparin therapy during pregnancy. Risks to the fetus and mother

1 reference

12 December 2020

Role of the geneticist in testing and counseling for inherited thrombophilia

1 reference

12 December 2020

Familial thrombophilia: genetic risk factors and management

1 reference

12 December 2020

Congenital antithrombin III deficiency. Incidence and clinical features

1 reference

12 December 2020

Cardiology patient pages. Prothrombin 20210 mutation (factor II mutation).

1 reference

12 December 2020

Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase

1 reference

12 December 2020

ACOG Practice Bulletin #68: Antiphospholipid syndrome

1 reference

12 December 2020

Thrombophilia in pregnancy: a systematic review

1 reference

12 December 2020

INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA

1 reference

12 December 2020

Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children

1 reference

12 December 2020

Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies

1 reference

12 December 2020

Prevalence of protein C deficiency in the healthy population

1 reference

12 December 2020

Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.

1 reference

12 December 2020

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

12 December 2020

Antithrombin III activity in healthy blood donors: age and sex related changes and prevalence of asymptomatic deficiency

1 reference

12 December 2020

The risk of recurrent venous thromboembolism in patients with and without factor V Leiden

1 reference

12 December 2020

Laboratory testing for prothrombotic states: clinical utility

1 reference

12 December 2020

Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease

1 reference

12 December 2020

Genetic polymorphisms associated with venous and arterial thrombosis: an overview

1 reference

12 December 2020

Initial treatment of venous thromboembolism

1 reference

12 December 2020

Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?

1 reference

12 December 2020

Oral contraception and factor V Leiden mutation in relation to localization of deep vein thrombosis

1 reference

12 December 2020

Thrombophilic disorders and fetal loss: a meta-analysis

1 reference

12 December 2020

Knowledge and educational needs of individuals with the factor V Leiden mutation

1 reference

12 December 2020

Antiphospholipid antibodies

1 reference

12 December 2020

Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism

1 reference

12 December 2020

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor

1 reference

12 December 2020

Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S.

1 reference

12 December 2020

Thrombophilia and recurrent fetal loss-related?

1 reference

12 December 2020

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders

1 reference

12 December 2020

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

12 December 2020

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

12 December 2020

Hyperhomocysteinemia as a risk factor for venous thrombosis

1 reference

12 December 2020

Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception

1 reference

12 December 2020

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

12 December 2020

Prevention of deep vein thrombosis in orthopedic surgery

1 reference

12 December 2020

Laboratory markers in the diagnosis of venous thromboembolism

1 reference

12 December 2020

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study

1 reference

12 December 2020

Antithrombin deficiency: issues in laboratory diagnosis

1 reference

12 December 2020

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

1 reference

12 December 2020

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden

1 reference

12 December 2020

Cardiology patient page. Factor V Leiden

1 reference

12 December 2020

Thrombophilia screening: a matter of debate.

1 reference

12 December 2020

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives

1 reference

12 December 2020

Inherited thrombophilias in pregnant patients: detection and treatment paradigm

1 reference

12 December 2020

Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism

1 reference

12 December 2020

Pros and cons of thrombophilia testing: pros.

1 reference

12 December 2020

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study

1 reference

12 December 2020

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

12 December 2020

Absence of thrombosis in subjects with heterozygous protein C deficiency

1 reference

12 December 2020

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Severe preeclampsia and high frequency of genetic thrombophilic mutations

1 reference

12 December 2020

Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?

1 reference

12 December 2020

Venous thrombosis: the role of genes, environment, and behavior

1 reference

12 December 2020

Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice

1 reference

12 December 2020

Risk factors in venous thromboembolism

1 reference

12 December 2020

Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study

1 reference

12 December 2020

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

1 reference

12 December 2020

The impact of venous thrombosis on quality of life

1 reference

12 December 2020

Prevention of venous thromboembolism: recommendations based on the International Consensus and the American College of Chest Physicians Sixth Consensus Conference on Antithrombotic Therapy.

1 reference

12 December 2020

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

1 reference

12 December 2020

Thrombophilias--practical implications and testing caveats

1 reference

12 December 2020

Anticoagulants in pregnancy

1 reference

12 December 2020

The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation

1 reference

12 December 2020

The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population

1 reference

12 December 2020

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

1 reference

12 December 2020

American College of Medical Genetics consensus statement on factor V Leiden mutation testing

1 reference

12 December 2020

Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia.

1 reference

12 December 2020

Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis

1 reference

12 December 2020

Genetic susceptibility to venous thrombosis

1 reference

12 December 2020

Venous thromboembolism and anticoagulant therapy in pregnancy

1 reference

12 December 2020

Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups

1 reference

12 December 2020

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

1 reference

12 December 2020

Homocysteine lowering and cardiovascular events after acute myocardial infarction

1 reference

12 December 2020

Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors

1 reference

12 December 2020

Measurement and use of total plasma homocysteine. American Society of Human Genetics/American College of Medical Genetics Test and Transfer Committee Working Group

1 reference

12 December 2020

Internal jugular vein thrombosis following in-vitro fertilization in a woman with protein S deficiency and heterozygosity for the prothrombin 3' UTR mutation, despite anticoagulation with heparin

1 reference

12 December 2020

Prevalence of the G20210A polymorphism in the 3'-untranslated region of the prothrombin gene in different human populations.

1 reference

12 December 2020

College of American Pathologists Consensus Conference XXXVI: Diagnostic Issues in Thrombophilia

1 reference

12 December 2020

Venous thromboembolic prophylaxis in hospitalized medical patients

1 reference

12 December 2020

ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists

1 reference

12 December 2020

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

1 reference

12 December 2020

ACOG practice bulletin. Thrombembolism in pregnancy

1 reference

12 December 2020

Inherited risk factors for venous thrombosis

1 reference

12 December 2020

The epidemiology of venous thromboembolism in the community: implications for prevention and management

1 reference

12 December 2020

Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool

1 reference

12 December 2020

Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial

1 reference

12 December 2020

Thrombophilia as a multigenic disorder

1 reference

12 December 2020

Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism

1 reference

12 December 2020

Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency.

1 reference

12 December 2020

First-trimester repeated abortion is not associated with activated protein C resistance

1 reference

12 December 2020

Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories

1 reference

12 December 2020

10.1007/S10897-006-9069-9

Identifiers

DOI

1 reference

release_fhtkvjs6cjfypagrfaxuzlkome

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fhtkvjs6cjfypagrfaxuzlkome

24 November 2022

mapped directly with Wikidata item

PubMed ID

17473965

1 reference

PubMed ID

17473965